GeneFerm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023 at 05:08 pm EDT
Share
GeneFerm Biotechnology Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 231.89 million compared to TWD 153.72 million a year ago. Net income was TWD 46.81 million compared to TWD 30.02 million a year ago. Basic earnings per share from continuing operations was TWD 1.13 compared to TWD 0.72 a year ago. Diluted earnings per share from continuing operations was TWD 1.13 compared to TWD 0.72 a year ago.
For the six months, sales was TWD 415.66 million compared to TWD 297.63 million a year ago. Net income was TWD 77.28 million compared to TWD 50.52 million a year ago. Basic earnings per share from continuing operations was TWD 1.86 compared to TWD 1.23 a year ago. Diluted earnings per share from continuing operations was TWD 1.86 compared to TWD 1.17 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.